StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$10.41−1.33 (-11.33%)

Close on Nov 18, 2026Market cap $70.68MP/E –Yield –

Eloxx Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Eloxx Pharmaceuticals's market cap was $52.51M on Nov 11, 2026, against $3.89K a year earlier. Over the last 5 years it ranged from $3 to $673.63M, with a median of $33.23M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$52.51M+1350556.8%
2025Dec 31, 2025$3.89K+129500.0%
2024Dec 31, 2024$3-100.0%
2023Dec 29, 2023$28.60M-34.1%
2022Dec 30, 2022$43.37M-93.6%
2021Dec 31, 2021$673.63M-61.7%
2020Dec 31, 2020$1.76B-45.7%
2019Dec 31, 2019$3.24B-30.3%
2018Dec 31, 2018$4.64B+157.3%
2017Dec 29, 2017$1.80B–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?